NewsRoom Articles - Page 1209 of 1410

WednesdaySep 27, 2017 3:30 pm

Midatech Pharma PLC (NASDAQ: MTP) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Midatech Pharma (NASDAQ: MTP) is an international specialty pharmaceutical company focused on oncology. The company’s approach comprises of developing oncology products internally and collaborating with partners in other therapy areas. The company’s strategy also involves driving growth both organically and through strategic acquisitions. Midatech is currently engaged in the US commercial operation of marketing four cancer care supportive products and co-promoting two others. Additionally, the company supports its research and development activities through its two breakthrough drug delivery technologies; the company’s proprietary gold nanoparticles and Q-Sphera for sustained release. For more information, visit the company’s website at www.midatechpharma.com. About NetworkNewsWire…

WednesdaySep 27, 2017 3:18 pm

InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Targets Specific Diseases with its Proprietary Biotechnologies

Provisional patent application protects unique process yielding pharmaceutical grade, bio-identical cannabinoids Proprietary research allows production of synthetic cannabinoids for therapeutic use with certain diseases Early stage clinical trials are expected to begin in 2018 for a drug targeting a rare children’s skin disorder Imagine having a painful disease that causes your skin to blister at the slightest minor injury. Even just scratching an itch or accidentally rubbing against a rough object could cause peeling blisters and acute suffering. Epidermolysis bullosa, a genetic connective tissue disorder that affects roughly one out of every 20,000 births in the United States, currently has…

WednesdaySep 27, 2017 3:00 pm

Rockwell Medical, Inc. (NASDAQ: RMTI) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Rockwell Medical (NASDAQ: RMTI) is a fully-integrated biopharmaceutical company with a focus on end-stage renal disease (ESRD) and chronic kidney disease (CKD). The company provides innovative products for the treatment of iron replacement, secondary hyperparathyroidism and hemodialysis. Triferic, the company’s anemia drug, is FDA approved for iron replacement and maintenance of hemoglobin in hemodialysis patients. The company also has an FDA approved generic drug, Calcitriol, for treating secondary hyperparathyroidism in dialysis patients. Rockwell also manufactures high-quality hemodialysis concentrates/dialysates to dialysis providers and distributors in the U.S. and abroad. For more information, visit the company’s website at www.rockwellmed.com. About NetworkNewsWire NetworkNewsWire…

WednesdaySep 27, 2017 2:30 pm

Applied DNA Sciences, Inc. (NASDAQ: APDN) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Applied DNA Sciences (NASDAQ: APDN) provides molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and DNA mass production for diagnostics and therapeutics. The company’s proprietary DNA-based “CertainT™” platform can be used to identify, tag, test and track products to help assure authenticity, origin, traceability, sustainability and quality of products. SigNature® DNA describes the core technology ingredient that is at the heart of a family of uncopiable, security and authentication solutions such as SigNature® T and fiberTyping®, targeted toward textiles and apparel, BackTrac™ and DNAnet®, for anti-theft and loss prevention, and digitalDNA®, providing powerful track-and-trace. All…

WednesdaySep 27, 2017 2:30 pm

Chanticleer Holdings, Inc. (NASDAQ: HOTR) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Chanticleer Holdings (NASDAQ: HOTR) owns, operates and franchises fast casual and full-service dining concepts in the United States and internationally. Chanticleer owns and operates and franchises restaurant brands including American Burger Company, BGR - Burgers Grilled Right, Little Big Burger, Just Fresh and Hooters. For more information, visit the company’s website at www.chanticleerholdings.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As…

WednesdaySep 27, 2017 2:00 pm

Research Frontiers Inc. (NASDAQ: REFR) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Research Frontiers (NASDAQ: REFR) develops and markets the technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device (SPD-Smart) light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, light-control film made from the chemical emulsion, the light-control panels made by laminating the film, lamination services, and electronics to power end-products incorporating the film, as well as the end-products, such as windows, skylights, and sunroofs. Its SPD-Smart light-control technology is used in multiple product applications. For more information, visit the company’s website at www.smartglass.com. About NetworkNewsWire NetworkNewsWire (NNW)…

WednesdaySep 27, 2017 2:00 pm

Pura Naturals, Inc. (PNAT) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Pura Naturals (OTCQB: PNAT) has a household cleaning product that absorbs grease and grime while delivering unique soap infusion without harmful chemicals or the bacteria buildup common with typical sponge products. Pura Naturals' foam technology was developed in response to the gulf oil spill. The revolutionary foam absorbs grease while repelling water and inhibiting bacteria growth and odors. Pura Naturals is an earth-conscious company that prides itself on its plant-based products made from renewable resources with no petroleum by-products. For more information, visit the company’s website at www.puranaturalsproducts.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access…

WednesdaySep 27, 2017 1:34 pm

AppSwarm, Inc. (SWRM) Continues to Support the Games People Play as a Business Accelerator

At least 150 million Americans play games Business accelerator for mobile app developers Footprint in the mammoth video games market With the latest Entertainment Software Association (ESA) report revealing that half of America plays video games, the excitement surrounding AppSwarm, Inc.’s (OTC: SWRM) foray into the industry appears to be based on very robust rationales. AppSwarm is a business accelerator focused on acquiring software applications for all forms of devices. The company actively pursues partnerships with software development companies that exhibit historical profitability and growth capability. Leveraging its resources in capital, management, marketing and product development, AppSwarm is able to…

WednesdaySep 27, 2017 1:30 pm

ITUS Corp. (NASDAQ: ITUS) Starts Presentation at the 2017 Disruptive Growth Company Showcase

ITUS (NASDAQ: ITUS) is a cancer-focused biotechnology company that funds, develops, acquires and licenses emerging technologies. The company, through its subsidiary, Anixa Diagnostics Corporation, is developing a platform called Cchek™, a series of non-invasive, blood tests for the early detection of solid tumor based cancers. ITUS also frequently examines emergent technologies in related fields for further development and commercialization. For more information, visit the company’s website at www.ITUScorp.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social…

WednesdaySep 27, 2017 1:30 pm

Cancer Genetics, Inc. (NASDAQ: CGIX) Starts Presentation at the 2017 Disruptive Growth Company Showcase

Cancer Genetics (NASDAQ: CGIX) develops, commercializes and provides molecular and biomarker-based tests and services in the United States, India and China. Its tests enable physicians to personalize the clinical management of each individual patient by providing genomic information to diagnose, monitor and inform cancer treatment; and enable biotech and pharmaceutical companies involved in oncology trials to select candidate populations and reduce adverse drug reactions by providing information regarding genomic factors influencing subject responses to therapeutics. The company’s clinical services provide information on diagnosis, prognosis, and predicting treatment outcomes of cancers to guide patient management. For more information, visit the company’s…

Financial news and publishing for public and private companies

Contact us: 512.354.7000